Skip to content
Open access

Inflammatory macrophages promote metastatic potential in Triple-negative Breast Cancer through Integrated Stress Response signaling

Sep 2026 · Journal of Experimental & Clinical Cancer Research · 0 citations

TL;DR

The findings establish a macrophage-CXCL10-CXCR3-ISR signaling axis that fuels metastatic behavior in TNBC and identify this pathway as a potential node for therapeutic intervention.

Abstract

Triple-negative Breast Cancer (TNBC) is characterized by inflammatory myeloid infiltration and a high metastatic potential, however, the mechanisms by which macrophage-derived signals govern tumor cell plasticity remain poorly understood. Here, through patient transcriptomic analyses, in vitro functional studies, and in vivo metastasis models, we identify the Integrated Stress Response (ISR) as a critical tumor cell-intrinsic pathway that translates inflammatory macrophage-derived cues into metastatic competence. In breast cancer clinical cohorts, ISR programs are enriched in TNBC and associate with poor outcome and inflammatory macrophage infiltration. Functionally, we show that the inflammatory macrophage secretome triggers ISR-dependent invasion in TNBC cells. Mechanistically, we identify CXCL10 as a macrophage-derived mediator necessary and sufficient to induce ISR activation and invasion through CXCR3 receptor. Finally, we demonstrate that tumor-intrinsic ISR signaling promotes TNBC metastatic dissemination in vivo. Together, our findings establish a macrophage-CXCL10-CXCR3-ISR signaling axis that fuels metastatic behavior in TNBC and identify this pathway as a potential node for therapeutic intervention. Statement of sig nificance Inflammatory macrophages promote TNBC metastasis by activating the Integrated Stress Response via a CXCL10-CXCR3 paracrine loop. These results bridge the gap between inflammation and tumor-intrinsic stress signaling, uncovering a novel mechanistic axis for therapeutic intervention.

Read PDF

Similar papers

Review Open access Sep 2026

Tumor microenvironment-driven immune evasion in triple-negative breast cancer: mechanisms, clinical challenges, and therapeutic opportunities

TME-driven immune evasion in TNBC is summarized, emphasizing molecular heterogeneity, hot and cold immune phenotypes, immunosuppressive cellular networks, PD-1/PD-L1 signaling, stromal barriers, metastatic immune escape, advances in clinical immunotherapy, adverse effects, and emerging TME-directed strategies.

Hui Zhang, Kun Zhou, Na Li et al. · 0 citations
Review Open access Sep 2026

Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistance

This Review focuses on the two major origins of peritoneal macrophages, and describes how gastric cancer cells exploit their plasticity by metabolic signals, exosomal oncomiRs, paracrine factors and so on to push them into a pro-metastatic phenotype.

Min Chen, Yu-Yang Li, Hui-Nan Wang et al. · 0 citations
Open access Aug 2026

Bidirectional phenotypic transition in macrophages influences triple-negative breast cancer cell immune evasive patterns and response to chemotherapies in a co-culture spheroid model

An effective 3D co-culture system of breast cancer cells and integrated macrophages for studying dynamic cellular phenotype changes and reciprocal interactions in a heterogeneous environment to mimic aspects of the TME and enhance the accuracy of preclinical in vitro treatment response studies is presented.

Chen Cheng, Brett A. McGregor, J. Hur et al. · 0 citations
Open access Sep 2026

Breast cancer-associated fibroblast-derived exosomal miR-1290 promotes triple-negative breast cancer cell proliferation

It is demonstrated that treatment with the mTOR inhibitor rapamycin and the FDA-approved rapamycin analog everolimus effectively suppressed miR-1290-induced TNBC cell proliferation, suggesting a potential therapeutic strategy for TNBC.

Jinkwon Lee, Taesang Son, Gyeonghwa Kim et al. · 0 citations
Review Open access Sep 2026

TREM2⁺ tumor-associated macrophages in cancer: context-dependent biology, biomarkers and precision immunotherapy.

A context-dependent framework integrating macrophage heterogeneity, immunometabolism, spatial biology, biomarker development, and therapeutic decision-making to advance precision immunotherapy is proposed.

Xue-Jun Guo, Jing-Ya Yu, Xiao-Yan Lin et al. · 1 citation
Review Open access Sep 2026

The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials

Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastasis, therapeutic resistance, and an immunosuppressive TME representing major barriers to successful treatment. Among the chemokine signaling networks implicated in these processes, the CCL2–CCR2 axis has emerged as an important reg...

Yu-Jie Huang, Jia Ma, J. Bi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.